Em. Schwarz et al., Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis, J ORTHOP R, 18(6), 2000, pp. 849-855
Individuals who suffer from severe joint destruction caused by the various
arthritidies often undergo total joint arthroplasty. A major limitation of
this treatment is the development of aseptic loosening of the prosthesis in
as many as 20% of patients. The current paradigm to explain aseptic loosen
ing proposes that wear debris generated from the prosthesis initiates a mac
rophage-mediated inflammatory response by resident macrophages, leading to
osteoclast activation and bone resorption at the implant interface. No ther
apeutic interventions have been proved to prevent or inhibit aseptic loosen
ing. The development of therapeutic strategies is limited due to the absenc
e of a quantitative surrogate in which drugs can be screened rapidly in lar
ge numbers of animals. We have previously described a model in which titani
um particles implanted on mouse calvaria induce an inflammatory response wi
th osteolysis similar to that observed in clinical aseptic loosening. Here,
we present new methods by which the osteolysis in this model can be quanti
fied. We determined that 6-8-week-old mice in normal health have a sagittal
suture area of 50 (+/-6) mum(2), which contains approximately five osteocl
asts. As a result of the titanium-induced inflammation and osteolysis, the
sagittal suture area increases to 197 (+/-27) mum(2), with approximately 30
osteoclasts, after 10 days of treatment. The sagittal suture area and the
number of osteoclasts in the calvaria of sham-treated mice remained unchang
ed during the 10 days. We also determined the effects of pentoxifylline, a
drug that blocks the responses of tumor necrosis factor-a to wear debris, a
nd the osteoclast inhibitor alendronate. We found that both drugs effective
ly block wear debris-induced osteolysis but not osteoclastogenesis. In conc
lusion, we found the measurements made with this model to be reproducible a
nd to permit quantitative analysis of agents that are to be screened for th
eir potential to prevent aseptic loosening.